These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11313)

  • 1. Effect of disintegrant type upon the relationship between compressional pressure and dissolution efficiency.
    Khan KA; Rooke DJ
    J Pharm Pharmacol; 1976 Aug; 28(8):633-6. PubMed ID: 11313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disintegration properties of calcium phosphate dibasic dihydrate tablets.
    Khan KA; Rhodes CT
    J Pharm Sci; 1975 Jan; 64(1):166-8. PubMed ID: 1133695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K; Langguth P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant.
    Sallam E; Ibrahim H; Dahab RA; Shubair M; Khalil E
    Drug Dev Ind Pharm; 1998 Jun; 24(6):501-7. PubMed ID: 9876615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of binders in twin-screw wet granulation - Optimal combination of binder and disintegrant.
    Köster C; Kleinebudde P
    Eur J Pharm Biopharm; 2023 May; 186():55-64. PubMed ID: 36913991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-sorption properties of tablet disintegrants.
    Khan KA; Rhodes CT
    J Pharm Sci; 1975 Mar; 64(3):447-51. PubMed ID: 1151632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution.
    Gordon MS; Chowhan ZT
    J Pharm Sci; 1987 Dec; 76(12):907-9. PubMed ID: 3440935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution.
    Johnson JR; Wang LH; Gordon MS; Chowhan ZT
    J Pharm Sci; 1991 May; 80(5):469-71. PubMed ID: 1880728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation.
    van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1983 Aug; 5(4):165-71. PubMed ID: 6622211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionality of wet-granulated disintegrant in comparison to directly incorporated disintegrant in a poorly water-soluble tablet matrix.
    Veronica N; Lee ESM; Heng PWS; Liew CV
    Int J Pharm; 2024 Aug; 661():124467. PubMed ID: 39004293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area.
    Iwao Y; Tanaka S; Uchimoto T; Noguchi S; Itai S
    Int J Pharm; 2013 May; 448(1):1-8. PubMed ID: 23518366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional assessment of four types of disintegrants and their effect on the spironolactone release properties.
    Rojas J; Guisao S; Ruge V
    AAPS PharmSciTech; 2012 Dec; 13(4):1054-62. PubMed ID: 22899380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new apparatus for real-time assessment of the particle size distribution of disintegrating tablets.
    Quodbach J; Kleinebudde P
    J Pharm Sci; 2014 Nov; 103(11):3657-3665. PubMed ID: 25223505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.